COVID-19
Pfizer Trims 200 Positions at Michigan COVID Plant During Cost-Saving Measures
The decline in demand for its COVID-19 treatments has prompted Pfizer to initiate a cost-reduction strategy across the company, which ...
Moderna Reports $1.3B Loss and Cuts Back Production Amid Sales Dip
Moderna, once propelled to pharmaceutical prominence by its lucrative COVID-19 vaccine sales, now grapples with a decline in demand and ...
Moderna partners with CEPI to speed up vaccine development for future pandemics
Moderna is teaming up with the Coalition for Epidemic Preparedness Innovations (CEPI) to contribute to the 100 Days Mission, an ...
Merck boosts revenue outlook on COVID-19 pill Lagevrio demand
In a surprising turn of events, Merck’s COVID-19 antiviral pill, Lagevrio, has defied expectations by generating an astounding $640 million ...
Pfizer Faces Backlash for Raising Price of Covid Drug Paxlovid
Following Pfizer’s announcement to increase the cost of its COVID-19 treatment drug, Paxlovid, for the next year, the AIDS Healthcare ...
Pfizer Reduces Revenue Projection by $9 Billion Due to Declining COVID Sales, Prepares for Substantial Cost Reductions
As the COVID-19 pandemic transitions into an endemic phase, pharmaceutical companies have been bracing for a decline in demand for ...
Novavax partners with TV show star to promote COVID-19 vaccine choice and awareness
Novavax is gearing up for a robust marketing push to secure a share of the COVID-19 booster vaccine market this ...
Lagevrio, the first oral COVID-19 drug, to be available in US soon
As anticipated, the US government is in the process of phasing out its distribution of COVID-19 treatments. Merck & Co.’s ...
ModeX secures $168M from BARDA to develop antiviral drugs for pandemic threats
In yet another remarkable development in the world of biotech, ModeX Therapeutics, in partnership with Merck, has secured a substantial ...
Merck’s antiviral pill Lagevrio may have triggered new COVID variants, study suggests
As concerns about the coronavirus continue to loom, the spotlight is once again on the most widely used oral antiviral ...
COVID variants share common strategy to evade immune system, study finds
The spotlight on SARS-CoV-2, the virus responsible for COVID-19, has primarily focused on its spike protein, crucial for cell entry. ...
Gallup poll shows pharma industry’s reputation plunges to record low amid COVID-19 vaccine criticism
The pharmaceutical industry’s reputation in the United States has reached its lowest point in the 21st century, with a significant ...
Arcturus reports positive results for sa-mRNA COVID boosters in phase 1/2 trial
Amid a shrinking COVID-19 vaccine market, Arcturus Therapeutics is forging ahead with its mRNA candidate, revealing promising early data demonstrating ...
U.S. government hires Icon to run trial of new COVID-19 vaccines
Icon, a prominent Contract Research Organization (CRO), has been chosen by the US Department of Health and Human Services’ Biomedical ...
Arbutus scraps COVID-19 and RNA degradation programs after disappointing preclinical results
Arbutus Biopharma has made significant strategic shifts by discontinuing its involvement in COVID-19 research and RNA destabilizer programs, redirecting its ...
Moderna Claims New COVID-19 Vaccine Can Protect Against Pirola Variant
Moderna is vigorously advocating for the expedited approval of its updated COVID-19 vaccine in preparation for the upcoming fall vaccination ...
Tonix’s long COVID drug fails in pain but shows promise in fatigue
Tonix Pharmaceuticals’ experimental treatment for long COVID with fibromyalgia-like symptoms, TNX-102 SL, did not demonstrate a statistically significant improvement in ...
Bavarian Nordic Abandons COVID Booster After Failing to Protect Against New Variants
Bavarian Nordic, a Danish biotech firm, has faced a crossroads that shines a light on the ever-evolving nature of the ...
Diversifying Strategies as Vaccine Demand Shifts: COVID-19 Vaccine Manufacturers Anticipate Fall Inoculation Season
Amidst a challenging environment of declining demand for COVID-19 vaccines, producers are eagerly awaiting the upcoming fall inoculation season as ...
CDMO Experiences Downturn at Merck KGaA as COVID-Related Sales Plunge, Says CFO
Merck KGaA is facing the challenges it anticipated for 2023, with its contract manufacturing division and process solutions arm experiencing ...
Moderna finds promise in the private COVID vaccination market and the debut of RSV as sales plummet
Source – Fiercepharma As Moderna continues its operations beyond the pandemic, the biotech firm has increased its revenue projection for ...
Humanigen Struggles Amidst Failed Reverse Merger, Faces Looming Bankruptcy
Three years ago, Humanigen was on a promising trajectory with a COVID-19 therapy in advanced testing and shares valued at ...
In its COVID-19 vaccination lawsuits against Pfizer and BioNTech, CureVac makes further claims under the patent statute
Source – CureVac CureVac is intensifying its patent battle over COVID-19 vaccines by asserting additional claims against Pfizer and BioNTech ...
Multiple Myeloma: What You Need to Know About the Latest Advances
Multiple myeloma is a type of blood cancer that affects plasma cells, which are responsible for producing antibodies that help ...
Merck awards pandemic early warning system with a prize of €500,000
The annual Future Insight competition held by Germany’s Merck KGaA has awarded a €500,000 prize to Khalid Salaita, a professor ...
For its updated Covid-19 vaccine, Moderna submits a regulatory application to the European Medicines Agency
Source – Moderna On July 3, 2023 Moderna announced the submission of a regulatory application to the European Medicines Agency ...
Moderna Application For FDA Approval Of Updated Covid-19 Vaccine
Source – Moderna On June 22, 2023, a regulatory application for Moderna’s updated COVID-19 mRNA vaccine (mRNA-1273.815), which contains spike ...
A monovalent COVID booster is advised by the FDA advisory group
The FDA advisory panel recently reached a unanimous conclusion regarding COVID-19 vaccinations for the upcoming autumn. They recommended a transition ...
Comprehensive Guide to mRNA Vaccines: Advancements in COVID-19 Immunization
Introduction At our organization, we are dedicated to providing valuable information on the latest advancements in COVID-19 vaccines. In this ...
FDA committee to talk about choosing the right strain for the subsequent round of COVID-19 boosts
Source – FDA The FDA’s Advisory Committee on Vaccines and Related Biological Products will meet on 15 June to discuss ...
